A carregar...
Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
Multiple myeloma (MM) is an incurable malignancy of plasma cells with a clinical course characterized by multiple relapses and treatment refractoriness. While recent treatment advancements have extended overall survival (OS), refractory MM has a poor prognosis, with a median OS of between 4 and 6 mo...
Na minha lista:
| Publicado no: | Target Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7570401/ https://ncbi.nlm.nih.gov/pubmed/33074469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-020-00758-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|